No one should face hereditary cancer alone.

Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.

Understanding BRCA & HBOC > Risk Management > Ovarian Cancer Screening

| More

Ovarian Cancer Screening

Learn about the steps that high-risk women can take to manage their risk and protect their health.

Related Force Information

Confronting Hereditary Breast and Ovarian Cancer
This FORCE-endorsed book was written by founder and Executive Director Sue Friedman; geneticist Rebecca Sutphen, MD; and health writer, Kathy Steligo. This book is a comprehensive resource on all topics related to hereditary cancer, genetic testing, and risk-management.

GOG-0199: The National Ovarian Cancer Prevention and Early Detection Study
Article from Spring 2012 Joining FORCEs Newsletter with updates on the research from GOG-199, a large, multicenter study on ovarian cancer detection and prevention.

Does ovarian cancer start in the fallopian tubes? How does this affect screening and prevention?
2011 Webinar. Dr. Kauff discusses the latest research and expert opinions on whether most hereditary ovarian cancer begins in the fallopian tubes and approaches to ovarian cancer screening based on these findings

Testing for Early Stage Ovarian Cancer
Article from 2008 Summer edition of Joining FORCEs Newsletter on the progress on early detection tests for ovarian cancer.

Ovarian Cancer Prevalence and Early Detection
Summer 2006 Joining FORCEs Newsletter article about efforts to develop early detection for ovarian cancer for high-risk women.

Books

Other Websites

Decision Tool for Women with BRCA Mutations
Developed by researchers at Stanford University, this tool is designed to help women with BRCA mutations understand the risks and survival benefits for each risk-management option in order to make the decision that is right for them.

National Comprehensive Cancer Network
The National Comprehensive Cancer Network is a consortium of experts in the field of oncology. The NCCN publishes a consensus guide for risk management options in high risk women with input from the top geneticists and experts in high-risk management.